{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:22:40Z","timestamp":1772752960960,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jiac.2026.102907","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:10:37Z","timestamp":1767975037000},"page":"102907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Microbiologic clearance in macrolide-resistant Bordetella pertussis: An infant treated with sulfamethoxazole-trimethoprim \u2014 A case timeline"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0059-1774","authenticated-orcid":false,"given":"Yu","family":"Kuramochi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1477-1415","authenticated-orcid":false,"given":"Meiwa","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Tame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5875-1024","authenticated-orcid":false,"given":"Yuho","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jiac.2026.102907_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00006454-199505000-00010","article-title":"Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis","volume":"14","author":"Lewis","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.jiac.2026.102907_bib2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/antibiotics11111570","article-title":"Macrolide resistance in Bordetella pertussis: current situation and future challenges","volume":"11","author":"Ivaska","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2026.102907_bib3","first-page":"100098","article-title":"Wirsing von K\u00f6nig C.H. Emerging macrolide resistance in Bordetella pertussis in mainland China: findings and warning from the Global Pertussis Initiative","volume":"8","author":"Feng","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jiac.2026.102907_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106289","article-title":"Global resurgence of pertussis: a perspective from China","volume":"89","author":"Liu","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2026.102907_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jgar.2022.10.007","article-title":"Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia","volume":"31","author":"Koide","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"10.1016\/j.jiac.2026.102907_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7883\/yoken.JJID.2019.421","article-title":"The first report of macrolide-resistant Bordetella pertussis isolation in Japan","volume":"73","author":"Yamaguchi","year":"2020","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jiac.2026.102907_bib10","doi-asserted-by":"crossref","first-page":"107960","DOI":"10.1016\/j.ijid.2025.107960","article-title":"Severe macrolide-resistant Bordetella pertussis (ptxP3) infection in Japanese infants: first report of cases requiring intensive care","volume":"158","author":"Tsukahara","year":"2025","journal-title":"Int J Infect Dis"},{"issue":"7","key":"10.1016\/j.jiac.2026.102907_bib11","doi-asserted-by":"crossref","first-page":"102727","DOI":"10.1016\/j.jiac.2025.102727","article-title":"Fatal case of macrolide-resistant Bordetella pertussis infection, Japan, 2024","volume":"31","author":"Iwasaki","year":"2025","journal-title":"J Infect Chemother"},{"issue":"Suppl 4","key":"10.1016\/j.jiac.2026.102907_bib13","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1093\/cid\/ciw521","article-title":"Comparing the yield of nasopharyngeal swabs, nasal aspirates, and induced sputum for detection of Bordetella pertussis in hospitalized infants","volume":"63","author":"Nunes","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2026.102907_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106373","article-title":"Resurgence of pertussis in China: evaluating the efficacy of sulfamethoxazole-trimethoprim as an alternative treatment","volume":"90","author":"Zhu","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2026.102907_bib15","article-title":"Levofloxacin is as effective as trimethoprim-sulfamethoxazole for the treatment of pertussis: a prospective observational study","author":"Wang","year":"2025","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"10.1016\/j.jiac.2026.102907_bib16","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1128\/JCM.01371-10","article-title":"Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis","volume":"48","author":"Riffelmann","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.102907_bib17","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA). Prescription drugs information for healthcare professionals: baktar (sulfamethoxazole\/trimethoprim). https:\/\/www.pmda.go.jp\/PmdaSearch\/rdSearch\/02\/6290100F3022?user=1 [accessed 9 October 2025]. [in Japanese)]."},{"key":"10.1016\/j.jiac.2026.102907_bib18","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Co-trimoxazole for infusion \u2014 summary of product characteristics (SmPC). emc. https:\/\/www.medicines.org.uk\/emc\/product\/4669\/smpc [accessed 9 October 2025]."},{"issue":"2","key":"10.1016\/j.jiac.2026.102907_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1542\/peds.2005-0395","article-title":"Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns","volume":"117","author":"Wennberg","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jiac.2026.102907_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/01480545.2013.834349","article-title":"Cotrimoxazole and neonatal kernicterus: a review","volume":"37","author":"Thyagarajan","year":"2014","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.jiac.2026.102907_bib22","first-page":"108","year":"2025"},{"issue":"31","key":"10.1016\/j.jiac.2026.102907_bib23","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/j.vaccine.2017.05.082","article-title":"A cross-sectional survey measuring sero-incidence of pertussis infection among Japanese junior and senior high school students in 2013 and 2014","volume":"35","author":"Ikematsu","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jiac.2026.102907_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jiac.2019.03.027","article-title":"Vaccine-acquired pertussis immunity was weakened at 4 years of age and asymptomatic pertussis infection was suspected based on serological surveillance","volume":"25","author":"Nakayama","year":"2019","journal-title":"J Infect Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2026.102907_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vaccine.2020.11.035","article-title":"Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: a test-negative case-control study in Japan","volume":"39","author":"Ohfuji","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jiac.2026.102907_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapediatrics.2022.5689","article-title":"US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and acellular pertussis vaccine","volume":"177","author":"Skoff","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"12","key":"10.1016\/j.jiac.2026.102907_bib28","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3390\/vaccines10121990","article-title":"Vaccination in pregnancy against pertussis: a consensus statement on behalf of the global pertussis initiative","volume":"10","author":"Abu-Raya","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"20","key":"10.1016\/j.jiac.2026.102907_bib29","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.vaccine.2018.01.048","article-title":"School-age children and adolescents suspected of having been to be infected with pertussis in Japan","volume":"36","author":"Yasui","year":"2018","journal-title":"Vaccine"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2600005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2600005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:41:02Z","timestamp":1770205262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2600005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1341321X2600005X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102907","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiologic clearance in macrolide-resistant Bordetella pertussis: An infant treated with sulfamethoxazole-trimethoprim \u2014 A case timeline","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102907"}}